Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Frontiers in Oncology
|
September 6, 2021
Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment <i>via</i> Notch2-Jagged1 Interaction in Lung Cancer
Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, et al.
The Kaohsiung Journal of Medical Sciences
|
September 26, 2025
Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer
Chia-Yu Kuo, Tien-Chi Huang, Chih-Jen Yang, et al.
Cancer Research
|
January 7, 2006
Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells
Fu Ou-Yang, Keng-Li Lan, Chun-Te Chen, et al.
International Journal of Molecular Sciences
|
March 4, 2020
Upregulation of <i>Thr</i>/<i>Tyr kinase</i> Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, et al.
Cancers
|
January 11, 2022
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
Yu-Chen Tsai, Hsiao-Ling Chen, Tai-Huang Lee, et al.
Journal of Personalized Medicine
|
July 2, 2021
The Downregulation of <i>LSAMP</i> Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, et al.
Biology
|
May 28, 2022
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, et al.
The Kaohsiung Journal of Medical Sciences
|
March 25, 2024
Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
International Journal of Molecular Sciences
|
July 26, 2020
Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, et al.
Cancers
|
January 8, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Frontiers in Oncology
|
September 6, 2021
Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment <i>via</i> Notch2-Jagged1 Interaction in Lung Cancer
Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, et al.
The Kaohsiung Journal of Medical Sciences
|
September 26, 2025
Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR-Mutated Advanced Nonsmall-Cell Lung Cancer
Chia-Yu Kuo, Tien-Chi Huang, Chih-Jen Yang, et al.
Cancer Research
|
January 7, 2006
Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells
Fu Ou-Yang, Keng-Li Lan, Chun-Te Chen, et al.
International Journal of Molecular Sciences
|
March 4, 2020
Upregulation of <i>Thr</i>/<i>Tyr kinase</i> Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer
Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, et al.
Cancers
|
January 11, 2022
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
Yu-Chen Tsai, Hsiao-Ling Chen, Tai-Huang Lee, et al.
Journal of Personalized Medicine
|
July 2, 2021
The Downregulation of <i>LSAMP</i> Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, et al.
Biology
|
May 28, 2022
Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma
Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, et al.
The Kaohsiung Journal of Medical Sciences
|
March 25, 2024
Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
International Journal of Molecular Sciences
|
July 26, 2020
Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2α Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
Ying-Ming Tsai, Kuan-Li Wu, Yung-Yun Chang, et al.
Cancers
|
January 8, 2023
Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, et al.
Page
of 14